We need a dedicated framework that clarifies the rules, requirements and incentives for those building personalized ...

There’s no questioning that AI should have governance and guardrails. As much good as it can bring, it also heightens risk.

Amid a season of regulatory and scientific advances, experts reveal a culture of data hoarding among cell and gene therapy ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

By emphasizing scientific uncertainty above other values, political appointees can block any regulatory action they want to.

SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex ...

The Global Metabolism Drugs Market, valued at approximately USD 16.10 billion in 2022, is projected to grow at a robust CAGR of more than 6.50% during the forecast period from 2023 to 2030. Metabolism ...

Artificial intelligence (AI) is already indispensable in the healthcare and life sciences sector. Intelligent medical devices promise nothing ...

Day trading is a risky investment strategy that involves buying and selling securities, such as stocks, on the same trading ...

Commercialisation of the trade requires cohesive regulation regarding cultivation, processing, distribution, retail, ...

Stevanato has invested significant resources in expanding its operations. Click to read more on STVN's Buy rating and its ...